Comments
Drug maker Lupin on Thursday said it has launched Fluocinonide ointment, used to treat inflammatory and pruritic manifestations, in the US market.
The product is a generic version of County Line Pharmaceuticals LLC’s Lidex ointment, Lupin said in a statement.
The ointment is indicated for relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.
According to IQVIA MAT January data, Fluocinonide ointment USP had annual sales of around $15 million (about Rs 103 crore) in the US.
Shares of Lupin ended 0.01 per cent down at Rs 724.70 apiece on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.